• Immunome Chief Medical Officer Robert Lechleider exercised employee stock options for 55,000 shares on July 2, 2026 at USD 8.73.
• He sold 55,000 shares the same day in three tranches at weighted-average prices of USD 21.95, USD 22.76, USD 23.44.
• Directly held common stock fell to 15,805 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunome Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001997584-26-000004), on July 07, 2026, and is solely responsible for the information contained therein.